Zopiclone 7.5 mg (Zopisign)

Zopisign 7.5 mg is a tablet formulation of zopiclone, a non-benzodiazepine hypnotic agent prescribed for the short-term management of insomnia. It is commonly used to treat difficulty falling asleep, frequent nighttime awakenings, and poor sleep quality.

Zopiclone works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that has calming effects on the brain. By binding to GABA-A receptors, it produces a sedative and relaxing effect that helps initiate and maintain sleep. Although it acts on similar receptors as benzodiazepines, it has a different chemical structure and is classified separately.

The 7.5 mg dose is a standard adult dose and is usually taken just before bedtime. It should only be used when the person can dedicate 7–8 hours to sleep. Zopiclone is generally recommended for short-term use, as prolonged use may lead to tolerance, dependence, or withdrawal symptoms.

Common side effects may include a bitter or metallic taste, dry mouth, drowsiness, dizziness, and headache. Rare but serious side effects can include confusion, memory problems, sleep-related behaviors (such as sleepwalking), mood changes, or allergic reactions.

Zopisign 7.5 mg should be used under medical supervision, particularly in individuals with liver disease, respiratory conditions, a history of substance misuse, or mental health disorders. Alcohol should be avoided while taking this medication due to the increased risk of excessive sedation and breathing difficulties.